Registration Options

Activity Dates: 12/12/2024 - 06/12/2025

Target Audience

BCPPs who value and learn through case-based literature offering therapeutic advice on both evidence and longstanding clinical experience are the target audience for this product. New and experienced BCPPs desiring insights into the strategies of clinical decision-making used by expert clinicians will find value in this product as the articles focus on disease states, their pharmacotherapy, and the synthesis of solutions to challenges that require judgement(s) founded on evidence but modified or tempered by extensive clinical experience and practicalities of "real world" necessities.

Content

Psychopharmacology Pearls is an application-based continuing pharmacy education (CPE) activity that allows users to gain greater insights into the strategies of clinical decision-making used by expert clinicians through four clinical articles developed and distributed annually via AAPP's peer-reviewed journal, The Mental Health Clinician (MHC). The articles developed for the Pearls product are not designed to replace typical review articles. Instead, they are meant to focus on a single disorder, or on one or more distinct aspects of a single psychiatric, neurologic, or substance use disorder, offering therapeutic advice based on both evidence and clinical expert experience.

Articles are authored by experts in the field and provide references that serve to highlight both the evidence base available and also challenging areas of clinical care. Articles reflect the views and practice of each author, who are required to call attention to both evidence-based facts as well as opinion and experience.
 
An application-based CPE activity requires that participants apply the information learned. In an application-based CPE activity, the learning objectives are written at a higher level in order to assess the learner's ability to use the information that is learned, at the expected level of practice of Board Certified Psychiatric Pharmacists. The examination for this product often features cases requiring that the participant apply the principles learned through the readings.
 
The Psychopharmacology Pearls product includes:
  • Four (4) articles in an electronic format.
  • Five (5) hours of ACPE credit and 5 hours of BCPP Recertification credit achieved by successfully completing the online AAPP recertification examination. ACPE credit is reported to CPE Monitor at nabp.net within 48 hours after successful completion of the examination. BCPP Recertification credit is earned and reported within the year the assessment is successfully completed (2024 or 2025).
  • Access to the AAPP testing center with exam submission due by June 12, 2025.

Course Requirements

To satisfactorily complete the Psychopharmacology Pearls and receive 5 hours of BCPP Recertification and ACPE credit, candidates must meet the following requirements:

  1. Abide by a confidentiality and honesty statement requiring individual completion of the recertification education.
  2. Successfully complete an online examination on or before the deadline of June 12, 2025.
  3. Meet the minimum passing score on the final examination as determined by a panel of experts.
  4. Partial credit is not available.
  5. Learners who do not achieve a passing score on a post-activity assessment may appeal assessment questions and/or request a remediation assessment. View AAPP's Post-Activity Assessment Appeal and Remediation Policy.

You will proceed through the following steps to satisfactorily complete this course:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Complete the pre-test before starting the activity.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date.
  • Complete the evaluation at the end of the activity.
  • If necessary, complete the post-test retest no later than the closing activity date.
  • Wait for the official review of exam questions within 4 weeks following the closing date.
  • Receive a passing grade (75%).
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Credit is awarded in the calendar year the assessment is completed. AAPP reports continuing credit for ACPE (CPE Monitor) and BCPP Recertification (BPS) within days of successful exam completion.

Faculty Information

Dana Chiulli, PharmD, BCPP
Courtney Iuppa, PharmD, BCPP
Kayla Johnson, PharmD, BCPS, BCPP
Megan O’Connell, PharmD, BCPP
Amy VandenBerg, PharmD, BCPP

View biographical information

Learning Objectives

Suicide Risk Identification and Mitigation in Patients with Chronic Pain Prescribed Opioid Medication 
  1. Apply risk mitigation strategies to patients with suicidality who are taking opioids for complex pain syndromes.
  2. Determine an appropriate opioid taper for a patient with chronic pain and suicidality based on patient-specific factors.
  3. Recommend a treatment plan, including modifiable risk factors, for a patient experiencing suicidality related to chronic pain.

Involuntary Medication Treatment of Schizophrenia in the Inpatient Setting

  1. Interpret clinical features and treatment issues as applicable to patients receiving involuntary treatment of schizophrenia.
  2. Evaluate risks and benefits of available treatment options for schizophrenia and the evidence supporting them.
  3. Apply evidence and/or expert opinion to optimize involuntary treatment for a patient with schizophrenia.

Clinical experience and treatment considerations with Vesicular Monoamine Transporter 2 Inhibitors

  1. Educate patients on the potential risks and benefits of VMAT2i therapy.
  2. Design a therapeutic treatment plan for a patient initiating VMAT2i treatment.
  3. Assess the evidence for use of VMAT2i outside of Food and Drug Administration approved labeling.

Clinical Pearls for the Management of Duloxetine in Patients with Medical Comorbidities

  1. Interpret pharmacokinetic information related to duloxetine treatment.
  2. Evaluate risks and benefits of available treatment options for a patient with changes in nutrition status.
  3. Apply evidence and/or expert opinion to optimize duloxetine treatment for a patient with renal or hepatic impairment.
  4. Choose therapeutic management options for complex clinical situations involving duloxetine and interacting medications.

 

Continuing Education Credit and Disclosures

Activity Dates: 12/12/2024 - 06/12/2025
ACPE Contact Hours: 5
ACPE Numbers: 0284-0000-24-042-H01-P (Application), 0284-0000-24-043-H01-P (Application), 0284-0000-24-044-H01-P (Application), 0284-0000-24-045-H01-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.

ACPEThe American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Psychopharmacology Pearls product is an application-based program approved for 5 ACPE contact hours. To receive ACPE credit, pharmacists completing this programming are required to complete an evaluation of the course as well as pass an online examination.

Board Certified Psychiatric Pharmacists (BCPPs) may also receive 5 hours of BCPP Recertification Credit for the Psychopharmacology Pearls upon successful completion of an online examination.
 
The American Association of Psychiatric Pharmacists is approved as a Professional Development Provider for the Board Certified Psychiatric Pharmacist (BCPP) specialty by the Board of Pharmacy Specialties (BPS). This course is part of a 5 hour BCPP recertification product earned after successful completion of the associated BCPP recertification examination for the full product.
 
AAPP reports continuing credit for ACPE (CPE Monitor) and BCPP Recertification (BPS) within days of successful exam completion.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.